Epistemis

Fixed splitting of the second heart sound (R2)

Specialty: Cardiovascular.

  • persistent and fixed splitting of R2
  • doubling of the second heart sound not modifiable with respiration

Why it occurs

  • Atrial interatrial communication of the ostium secundum, ostium primum or venous sinus type
  • Complete right bundle branch block (RBBB)
  • Chronic severe right ventricular failure
  • Moderate to severe pulmonary valve stenosis with prolonged ejection
  • Ventricular communication with large shunt from left to right

Initial workup

12-lead electrocardiogram to look for the rSR' pattern in right precordial leads (V1-V2) indicative of right bundle branch block, right axis deviation and right ventricular hypertrophy; Transthoracic and transesophageal Doppler echocardiogram to directly visualize the interatrial septal defect, measure the direction and speed of the shunt, estimate the pulmonary and systemic flow ratio (Qp/Qs) and quantify the degree of dilation of the right chambers; Chest x-ray.

red flags

Presence of a splitting of the second heart sound that remains identical and audible in both inspiration and deep expiration, associated with progressive dyspnea on exertion, extreme fatigue, central cyanosis on exertion, palpitations of recent onset (such as fluttering or atrial fibrillation with rapid response), or signs of decompensated right ventricular failure (peripheral edema, jugular engorgement). It suggests chronic volumetric overload of the right ventricle with risk of developing irreversible pulmonary hypertension (Eisenmenger Syndrome).

Standard management

  • Furosemide — loop diuretic indicated if there are data of fluid overload of the right cavities; 20 to 40 mg once daily orally
  • Spironolactone — aldosterone receptor antagonist for water depletion and control of remodeling of the right cavities; 25 mg once daily orally
  • Warfarin — oral anticoagulant indicated if associated with atrial fibrillation or flutter secondary to chronic atrial stretching, to prevent cardioembolic events; dose adjusted to INR between 2.0 and 3.0
  • Enoxaparin (prophylaxis or treatment in the acute phase if there is suspicion of thrombosis or concomitant peripheral embolism; 1 mg/kg every 12 hours subcutaneously).

Educational guidance for study. It is NOT a prescription recommendation. The actual choice depends on the cause, the patient, and current guidelines.

Area
Cardiovascular
Listed causes
5
Treatment options
4
Download Epistemis